Pptn trifluoroacetate
CAS: 1160271-30-6
Ref. 3D-KWB27130
| 5mg | Descontinuado | ||
| 10mg | Descontinuado | ||
| 25mg | Descontinuado | ||
| 50mg | Descontinuado | ||
| 100mg | Descontinuado |
Informação sobre produto
Nome:
Pptn trifluoroacetate
Descrição:
Pptn trifluoroacetate is a drug candidate that is currently undergoing clinical trials as a potential treatment for Alzheimer's disease. It belongs to the group of pyridone derivatives, which are chemically related to butyrophenones. Pptn trifluoroacetate has been found to be effective in reducing the symptoms of Alzheimer's disease by inhibiting 5-HT1A receptor activation, which leads to increased brain levels of serotonin and dopamine. Pptn trifluoroacetate has also been found to have calcium binding properties that lead to increased release of acetylcholine from cells in the brain. This drug candidate has shown no significant side effects in animal studies and has been found to be safe for human use.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
475.5 g/mol
Fórmula:
C29H24F3NO2
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
